Higher circulating total IGF-I concentration is one of a limited number of established causal and potentially modifiable risk factors for prostate cancer risk, with strong evidence from both large prospective observational and genetic study designs [4–7, 15]. This evidence concerns the gene IGF1 and prostate carcinoma.